Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

Browse

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

Corrigendum to “Selinexor for the treatment of patients with relapsed or refractory multiple myeloma”

Journal of Oncology Pharmacy Practice

Impact Factor: 1.3 / 5-Year Impact Factor: 1.3

Journal Homepage Submission guidelines

Restricted access

Correction

First published online February, 2025

Corrigendum to “Selinexor for the treatment of patients with relapsed or refractory multiple myeloma”

Volume 31, Issue 1

https://doi.org/10.1177/10781552241301566

Abstract

Get full access to this article

View all access options for this article.

Browse journal

Current issue OnlineFirst All issues

Similar articles

Restricted access

The effects of a palliative care program on antidepressant use and continuing maintenance medications in near end-of-life oncology patients (the HEALED study)

Restricted access

Conference report: Oncology pharmacoeconomics The Seventh International Symposium on Oncology Pharmacy Practice,Prague,Czech Republic,April 5-8,2000

Restricted access

Transfusions increase with nationally driven reimbursement changes of erythropoiesis stimulating agents for chemotherapy-induced anemia

Restricted access

Incidence,outcome and predictors of bleomycin pulmonary toxicity in a university hospital in Oman